(EXO) Exor - Overview
Sector: Industrials | Industry: Farm & Heavy Construction Machinery | Exchange: AS (Netherlands) | Market Cap: 22.136m EUR | Total Return: -11.6% in 12m
Industry Rotation: -15.2
Avg Turnover: 17.3M EUR
Peers RS (IBD): 34.1
EPS Trend: -18.7%
Qual. Beats: 0
Rev. Trend: -60.8%
Qual. Beats: 0
Warnings
Low Hurst
Tailwinds
No distinct edge detected
Exor N.V. (EXO) is a diversified holding company headquartered in Amsterdam that controls leading businesses across automotive, agriculture, construction, media, and sports. Its portfolio includes luxury sports cars (Ferrari), mass-market vehicle brands (Stellantis group), agricultural and construction equipment (CNH Industrial, Iveco), the Juventus football club, and major publishing assets such as The Economist and La Repubblica.
In FY 2023 Exor reported €108 billion in consolidated revenue, a 5 % increase year-over-year, and net profit of €5.2 billion, supported by strong earnings from Stellantis (+7 % EBIT) and a 12 % rise in Ferrari’s operating margin. The group maintained a dividend yield of roughly 4.2 % and an EV/EBITDA multiple of 8.5×, placing it at the lower end of the automotive-industry average.
Key drivers for Exor’s segments include the global shift toward electric vehicles and stricter emissions standards boosting demand for powertrain and EV technologies, robust infrastructure spending in Europe and North America fueling sales of construction and agricultural equipment, and accelerating digital transformation in media and advertising that benefits its publishing and data-analytics businesses.
For deeper insights, you may explore ValueRay’s analysis.
- Ferrari luxury car demand drives revenue growth
- Stellantis vehicle sales impact automotive segment
- CNH Industrial agricultural equipment sales fluctuate with commodity prices
- Iveco Group commercial vehicle demand affects industrial performance
- Juventus football club performance influences media and entertainment revenue
| Net Income: 10.88b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.08 > 0.02 and ΔFCF/TA 2.40 > 1.0 |
| NWC/Revenue: 7.17% < 20% (prev 53.27%; Δ -46.11% < -1%) |
| CFO/TA 0.08 > 3% & CFO 2.91b > Net Income 10.88b |
| Net Debt (2.15b) to EBITDA (16.93b): 0.13 < 3 |
| Current Ratio: 2.21 > 1.5 & < 3 |
| Outstanding Shares: last quarter (207.6m) vs 12m ago -7.96% < -2% |
| Gross Margin: error (current vs previous; cannot be calculated due to missing/invalid data or negative margin) |
| Asset Turnover: 17.90% > 50% (prev 70.81%; Δ -52.91% > 0%) |
| Interest Coverage Ratio: 72.00 > 6 (EBITDA TTM 16.93b / Interest Expense TTM 213.0m) |
| A: 0.02 (Total Current Assets 1.55b - Total Current Liabilities 701.0m) / Total Assets 37.13b |
| B: -0.02 (Retained Earnings -624.0m / Total Assets 37.13b) |
| C: 0.23 (EBIT TTM 15.34b / Avg Total Assets 65.95b) |
| D: 8.55 (Book Value of Equity 33.24b / Total Liabilities 3.89b) |
| Altman-Z'' Score: 10.63 = AAA |
Over the past week, the price has changed by +0.99%, over one month by -5.15%, over three months by -11.54% and over the past year by -11.62%.
| Analysts Target Price | - | - |
P/S = 1.7692
P/B = 0.4097
Revenue TTM = 11.80b EUR
EBIT TTM = 15.34b EUR
EBITDA TTM = 16.93b EUR
Long Term Debt = unknown (none)
Short Term Debt = 629.0m EUR (from shortTermDebt, two quarters ago)
Debt = 3.54b EUR (from shortLongTermDebtTotal, two quarters ago)
Net Debt = 2.15b EUR (recalculated: Debt 3.54b - CCE 1.39b)
Enterprise Value = 24.29b EUR (22.14b + Debt 3.54b - CCE 1.39b)
Interest Coverage Ratio = 72.00 (Ebit TTM 15.34b / Interest Expense TTM 213.0m)
EV/FCF = 8.35x (Enterprise Value 24.29b / FCF TTM 2.91b)
FCF Yield = 11.98% (FCF TTM 2.91b / Enterprise Value 24.29b)
FCF Margin = 24.65% (FCF TTM 2.91b / Revenue TTM 11.80b)
Net Margin = 92.16% (Net Income TTM 10.88b / Revenue TTM 11.80b)
Gross Margin = unknown ((Revenue TTM 11.80b - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = 0.65 (Enterprise Value 24.29b / Total Assets 37.13b)
Interest Expense / Debt = 2.15% (Interest Expense 76.0m / Debt 3.54b)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 11.50b (EBIT 15.34b * (1 - 25.00%))
Current Ratio = 2.21 (Total Current Assets 1.55b / Total Current Liabilities 701.0m)
Debt / Equity = 0.11 (Debt 3.54b / totalStockholderEquity, last quarter 33.24b)
Debt / EBITDA = 0.13 (Net Debt 2.15b / EBITDA 16.93b)
Debt / FCF = 0.74 (Net Debt 2.15b / FCF TTM 2.91b)
Total Stockholder Equity = 36.54b (last 4 quarters mean from totalStockholderEquity)
RoA = 16.49% (Net Income 10.88b / Total Assets 37.13b)
RoE = 29.77% (Net Income TTM 10.88b / Total Stockholder Equity 36.54b)
RoCE = 42.10% (EBIT 15.34b / Capital Employed (Total Assets 37.13b - Current Liab 701.0m))
RoIC = 28.49% (NOPAT 11.50b / Invested Capital 40.38b)
WACC = 7.20% (E(22.14b)/V(25.68b) * Re(8.09%) + D(3.54b)/V(25.68b) * Rd(2.15%) * (1-Tc(0.25)))
Discount Rate = 8.09% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -4.06%
[DCF] Terminal Value 84.26% ; FCFF base≈3.81b ; Y1≈4.70b ; Y5≈8.01b
[DCF] Fair Price = 804.9 (EV 164.93b - Net Debt 2.15b = Equity 162.78b / Shares 202.2m; r=7.20% [WACC]; 5y FCF grow 25.0% → 3.0% )
EPS Correlation: -18.74 | EPS CAGR: 477.7% | SUE: -4.0 | # QB: 0
Revenue Correlation: -60.80 | Revenue CAGR: -46.64% | SUE: -0.25 | # QB: 0
EPS current Year (2026-12-31): EPS=-8.44 | Chg7d=-4.948 | Chg30d=-4.948 | Revisions Net=+0 | Growth EPS=-442.1% | Growth Revenue=+0.0%
EPS next Year (2027-12-31): EPS=2.08 | Chg7d=-0.340 | Chg30d=-0.340 | Revisions Net=-1 | Growth EPS=+124.7% | Growth Revenue=+0.0%